The authors try to explain this result based on Biri et al.’s hypothesis: they studied prostate cancer and argued that the low SOD activity in cancer may be due to its inability to eliminate high concentrations of ROS [47]. The gene discussed is SOD1; the disease is prostate carcinoma.